Effect modification by δ-aminolevulinic acid dehydratase, vitamin D receptor, and nitric oxide synthase gene polymorphisms on associations between patella lead and renal function in lead workers

Environmental Research

Volumn 102, Issue 1, 2006, Pages 61-69

  Weaver, Virginia M ^a,b   Lee, Byung Kook ^c   Todd, Andrew C ^d   Ahn, Kyu Dong ^c   Shi, Weiping ^a   Jaar, Bernard G ^b,e   Kelsey, Karl T ^f   Lustberg, Mark E ^g   Silbergeld, Ellen K ^e   Parsons, Patrick J ^h   Wen, Jiayu ^a   Schwartz, Brian S ^a,b,e  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Soonchunhyang University   (South Korea)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e JOHNS HOPKINS UNIVERSITY   (United States)

^f HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^g UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^h WADSWORTH CENTER   (United States)

Author keywords

aminolevulinic acid dehydratase; Endothelial nitric oxide synthase; Lead exposure; Patella lead; Renal function; Tibia lead; Vitamin D receptor

Indexed keywords

CREATININE; LEAD; NITRIC OXIDE SYNTHASE; PORPHOBILINOGEN SYNTHASE; VITAMIN D RECEPTOR;

BIOMARKER; BONE; HEALTH RISK; LEAD; NITRIC OXIDE; OCCUPATIONAL EXPOSURE; POLYMORPHISM; TOXICITY; VITAMIN;

ADULT; ALLELE; ARTICLE; BIOAVAILABILITY; BLOOD; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; FEMALE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; KIDNEY FUNCTION; KOREA; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; PATELLA; PRIORITY JOURNAL; UREA NITROGEN BLOOD LEVEL;

ACETYLGLUCOSAMINIDASE; ADULT; BLOOD UREA NITROGEN; CREATININE; CROSS-SECTIONAL STUDIES; DNA; FEMALE; HUMANS; KIDNEY DISEASES; KOREA; LEAD; LEAD POISONING; LINEAR MODELS; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE III; OCCUPATIONAL EXPOSURE; PATELLA; POLYMORPHISM, GENETIC; PORPHOBILINOGEN SYNTHASE; RECEPTORS, CALCITRIOL; RETINOL-BINDING PROTEINS;

EID: 33746070801     PISSN: 00139351     EISSN: 10960953     Source Type: Journal    
DOI: 10.1016/j.envres.2006.01.001     Document Type: Article

References (42)

1. Chuang H.Y., Yu K.T., Ho C.K., Wu M.T., Lin G.T., and Wu T.N. Investigations of vitamin D receptor polymorphism affecting workers' susceptibility to lead. J. Occup. Health 46 (2004) 316-322
2. Cleveland W.S. Robust locally weighted regression and smoothing scatterplots. J. Am. Stat. Assoc. 74 (1979) 829-836
3. Cockcroft D.W., and Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976) 31-41
4. Fernandez F.J. Micromethod for lead determination in whole blood by atomic absorption, with use of the graphite furnace. Clin. Chem. 21 (1975) 558-561
5. Golser R., Gorren A.C., Mayer B., and Schmidt K. Functional characterization of Glu298Asp mutant human endothelial nitric oxide synthase purified from a yeast expression system. Nitric Oxide 8 (2003) 7-14
6. Hibi K., Ishigami T., Tamura K., Mizushima S., Nyui N., Fujita T., Ochiai H., Kosuge M., Watanabe Y., Yoshii Y., Kihara M., Kimura K., Ishii M., and Umemura S. Endothelial nitric oxide synthase gene polymorphism and acute myocardial infarction. Hypertension 32 (1998) 521-526
7. Hoffmann I.S., Tavares-Mordwinkin R., Castejon A.M., Alfieri A.B., and Cubeddu L.X. Endothelial nitric oxide synthase polymorphism, nitric oxide production, salt sensitivity and cardiovascular risk factors in Hispanics. J. Hum. Hypertens. 3 (2005) 233-240
8. Hu H., Rabinowitz M., and Smith D. Bone lead as a biological marker in epidemiological studies of chronic toxicity: Conceptual paradigms. Environ. Health Perspect. 106 (1998) 1-8
9. Kamel F., Umbach D.M., Lehman T.A., Park L.P., Munsat T.L., Shefner J.M., Sandler D.P., Hu H., and Taylor J.A. Amyotrophic lateral sclerosis, lead, and genetic susceptibility: polymorphisms in the delta-aminolevulinic acid dehydratase and vitamin D receptor genes. Environ. Health Perspect. 111 (2003) 1335-1339
10. Khalil-Manesh F., Gonick H.C., Cohen A.H., Alinovi R., Bergamaschi E., Mutti A., and Rosen V.J. Experimental model of lead nephropathy. I. Continuous high-dose lead administration. Kidney Int. 41 (1992) 1192-1203
11. Khalil-Manesh F., Gonick H.C., and Cohen A.H. Experimental model of lead nephropathy. III. Continuous low-level lead administration. Arch. Environ. Health 48 (1993) 271-278
12. Kim R., Aro A., Rotnitzky A., Amarasiriwardena C., and Hu H. K X-ray fluorescence measurements of bone lead concentration: the analysis of low-level data. Phys. Med. Biol. 40 (1995) 1475-1485
13. Li R., Lyn D., Lapu-Bula R., Oduwole A., Igho-Pemu P., Lankford B., Morgan J., Nkemdechi S., Liu G., Pack C., Silvestrov N., von Deutsch D.A., Song Q., Abukhalaf I.K., and Ofili E. Relation of endothelial nitric oxide synthase gene to plasma nitric oxide level, endothelial function, and blood pressure in African Americans. Am. J. Hypertens. 17 (2004) 560-567
14. Lee B.-K., Lee G.-S., Stewart W.F., Ahn K.-D., Simon D., Kelsey K.T., Todd A.C., and Schwartz B.S. Associations of blood pressure and hypertension with lead dose measures and polymorphisms in the vitamin D receptor and δ-aminolevulinic acid dehydratase genes. Environ. Health Perspect. 109 (2001) 383-389
15. Lustberg M.E., Schwartz B.S., Lee B.K., Todd A.C., and Silbergeld E.K. The G(894)-T(894) polymorphism in the gene for endothelial nitric oxide synthase and blood pressure in lead-exposed workers from Korea. J. Occup. Environ. Med. 46 (2004) 584-590
16. Moon J., Yoon S., Kim E., Shin C., Jo SA., and Jo I. Lack of evidence for contribution of Glu298Asp (G894 T) polymorphism of endothelial nitric oxide synthase gene to plasma nitric oxide levels. Thromb. Res. 15 (2002) 129-134
17. Nenov V.D., Taal M.W., Sakharova O.V., and Brenner B.M. Multi-hit nature of chronic renal disease. Curr. Opin. Nephrol. Hypertens. 9 (2000) 85-97
18. Noiri E., Satoh H., Taguchi J., Brodsky S.V., Nakao A., Ogawa Y., Nishijima S., Yokomizo T., Tokunaga K., and Fujita T. Association of eNOS Glu298Asp polymorphism with end-stage renal disease. Hypertension 40 (2002) 535-540
19. Onalaja A.O., and Claudio L. Genetic susceptibility to lead poisoning. Environ. Health Perspect. 108 suppl. 1 (2000) 23-28
20. Parsons P.J., and Slavin W. Electrothermal atomization atomic absorption spectrometry for the determination of lead in urine: results of an interlaboratory study. Spectrochim. Acta B 54 (1999) 853-864
21. Persu A., Stoenoiu M.S., Messiaen T., Davila S., Robino C., El-Khattabi O., Mourad M., Horie S., Feron O., Balligand J.-L., Wattiez R., Pirson Y., Chauveau D., Lens X.M., and Devuyst O. Modifier effect of eNOS in autosomal dominant polycystic kidney disease. Hum. Mol. Gen. 11 (2002) 229-241
22. Schwartz B.S., Lee B.-K., Lee G.-S., Stewart W.F., Simon D., Kelsey K., and Todd A.C. Associations of blood lead, dimercaptosuccinic acid-chelatable lead, and tibia lead with polymorphisms in the vitamin D receptor and δ-aminolevulinic acid dehydratase genes. Environ. Health Perspect. 108 (2000) 949-954
23. Schwartz B.S., Stewart W.F., Kelsey K.T., Simon D., Park S., Links J.M., and Todd A.C. Associations of tibial lead levels with BsmI polymorphisms in the vitamin D receptor in former organolead manufacturing workers. Environ. Health Perspect. 108 (2000) 199-203
24. Schwartz B.S., Lee B.K., Lee G.S., Stewart W.F., Lee S.S., Hwang K.Y., Ahn K.-D., Kim Y.-B., Bolla K.I., Simon D., Parsons P.J., and Todd A.C. Associations of blood lead, dimercaptosuccinic acid-chelatable lead, and tibia lead with neurobehavioral test scores in South Korean lead workers. Am. J. Epidemiol. 153 (2001) 453-464
25. Sofowora G., Dishy V., Xie H.-G., Imamura H., Nishimi Y., Morales C.R., Morrow J.D., Kim R.B., Stein C.M., and Wood A.J. In-vivo effects of Glu298Asp endothelial nitric oxide synthase polymorphism. Pharmacogenetics 11 (2001) 809-814
26. Tanus-Santos J.E., Desai M., Deak L.R., Pezzullo J.C., Abernethy D.R., Flockhart D.A., and Freedman J.E. Effects of endothelial nitric oxide synthase gene polymorphisms on platelet.function, nitric oxide release, and interactions with estradiol. Pharmacogenetics 12 (2002) 407-413
27. Theppeang K., Schwartz B.S., Lee B.K., Lustberg M.E., Silbergeld E.K., Kelsey K.T., Parsons P.J., and Todd A.C. Associations of patella lead with polymorphisms in the vitamin D receptor, delta-aminolevulinic acid dehydratase and endothelial nitric oxide synthase genes. J. Occup. Environ. Med. 46 (2004) 528-537
28. Todd A.C. Coherent scattering and matrix correction in bone-lead measurements. Phys. Med. Biol. 45 (2000) 1953-1963
29. Todd A.C. Contamination of in vivo bone-lead measurements. Phys. Med. Biol. 45 (2000) 229-240
30. Todd A.C., and Chettle D.R. Calculating the uncertainty in lead concentration for in vivo bone lead X-ray fluorescence. Phys. Med. Biol. 48 (2003) 2033-2039
31. 109Cd "spot" source. In: Ellis K.J., and Eastman J.D. (Eds). Human Body Composition Studies (1993), Plenum Press, New York 299-302
32. Todd A.C., Parsons P.J., Carroll S., Geraghty C., Khan F.A., Tang S., and Moshier E.L. Measurements of lead in human tibiae. A comparison between K-shell X-ray fluorescence and electrothermal atomic absorption spectrometry. Phys. Med. Biol. 47 (2002) 673-687
33. Topping M.D., Forster H.W., Dolman C., Luczynska C.M., and Bernard A.M. Measurement of urinary retinol-binding protein by enzyme-linked immunosorbent assay, and its application to detection of tubular proteinuria. Clin. Chem. 32 (1986) 1863-1866
34. Uitterlinden A.G., Fang Y., van Meurs J.B.J., Pols H.A.P., and van Leeuwen J.P.T.M. Genetics and biology of vitamin D receptor polymorphisms. Gene 338 (2004) 143-156
35. Veldman B.A., Spiering W., Doevendans P.A., Vervoort G., Kroon A.A., de Leeuw P.W., and Smits P. The Glu298Asp polymorphism of the NOS 3 gene as a determinant of the baseline production of nitric oxide. J. Hypertens. 20 (2002) 2023-2027
36. Weaver V.M., Lee B.-K., Ahn K.-D., Lee G.-S., Todd A.C., Stewart W.F., Wen J., Simon D.J., Parsons P.J., and Schwartz B.S. Associations of lead biomarkers with renal function in Korean lead workers. Occup. Environ. Med. 60 (2003) 551-562
37. Weaver V.M., Schwartz B.S., Ahn K.-D., Stewart W.F., Kelsey K.T., Todd A.C., Wen J., Simon D.J., Lustberg M.E., Parsons P.J., Silbergeld E.K., and Lee B.-K. Associations of renal function with polymorphisms in the δ-aminolevulinic acid dehydratase, vitamin D receptor, and nitric oxide synthase genes in Korean lead workers. Environ. Health Perspect. 111 (2003) 1613-1619
38. Weaver V.M., Lee B.-K., Todd A.C., Jaar B.G., Ahn K.-D., Wen J., Shi W., Parsons P.J., and Schwartz B.S. Associations of patella lead and other lead biomarkers with renal function in lead workers. J. Occup. Environ. Med. 47 (2005) 235-243
39. Weaver V.M., Schwartz B.S., Jaar B.G., Ahn K.-D., Todd A.C., Lee S.-S., Kelsey .T., Silbergeld E.K., Lustberg M.E., Parsons P.J., Wen J., and Lee B.-K. Associations of uric acid with polymorphisms in the δ-aminolevulinic acid dehydratase, Vitamin D receptor, and nitric oxide synthase genes in Korean lead workers. Environ. Health Perspect. 1 (2005) 1 10.1289/ehp.7927 [Online 27 June 2005]
40. Weisberg S. Applied Linear Regression (1985), Wiley, New York pp. 52-53
41. Wu M.-T., Kelsey K., Schwartz J., Sparrow D., Weiss S., and Hu H. A δ-aminolevulinic acid dehydratase (ALAD) polymorphism may modify the relationship of low-level lead exposure to uricemia and renal function: the Normative Aging Study. Environ. Health Perspect. 111 (2003) 335-340
42. Ye X.B., Wu C.E., Hua F., Yang S.L., Lu Y.W., and Ni W.M. Associations of blood lead levels, kidney function, and blood pressure with δ-aminolevulinic acid dehydratase and vitamin D receptor gene polymorphisms. Toxicol. Mechanisms Methods 13 (2003) 139-146